Ratos — AGM Information 2008

Mar 6, 2008

Ratos AB (publ), Drottninggatan 2 Box 1661 SE-111 96 Stockholm Sweden Org nr/Corp. Id. no. 556008-3585, Tel +46 8 700 17 00 Fax +46 8 10 25 59 www.ratos.se

PRESS RELEASE 6 March 2008

This information is disclosed in accordance with the Securities Markets Act, the Financial Instruments Trading Act or demands made in the exchange rules.

AGM 9 April 2008

Ratos's Annual General Meeting will be held on Wednesday, 9 April at 17.30 CET in Berwaldhallen, Stockholm. The complete notice of the meeting is available at www.ratos.se where attendance can also be notified. Complete AGM documentation will be available at Ratos's head office and on the company's website www.ratos.se from 12 March.

Board of Directors

The Nomination Committee proposes re-election of Board members Olof Stenhammar, Lars Berg, Staffan Bohman, Göran Grosskopf, Arne Karlsson (CEO), Annette Sadolin, Jan Söderberg and Per-Olof Söderberg. Göran Grosskopf has declined re-election. Olof Stenhammar is proposed as Chairman of the Board. Olof Stenhammar is also proposed as Chairman of the AGM.

Of the proposed Board members, Olof Stenhammar, who has been on the Board of the company for more than 12 years, and the company's CEO Arne Karlsson are non-independent Board members. Two Board members, Jan Söderberg and Per-Olof Söderberg, are non-independent of major shareholders. The remaining three Board members are independent of Ratos and its management.

A more detailed presentation of proposed Board members and the work of the Nomination Committee is provided on the company's website www.ratos.se.

Proposed dividend

The Board proposes an ordinary dividend of SEK 9.00 per share (5.50+5.50) of class A and B. The record date for the right to received dividends is proposed as 14 April and dividends are expected to be paid on 17 April.

Purchase of treasury shares

The Board of Directors proposes that the Annual General Meeting gives the Board a mandate to decide, during the period until the next Annual General Meeting, on repurchase of a maximum number of shares so that the company's holding of treasury shares does not exceed 7% of all the shares in the company. The purpose of the buybacks is to give the Board more room for manoeuvre in its work to create value for the company's shareholders.

Incentive programme

The Board proposes a decision to issue a maximum of 750,000 call options on repurchased Ratos-shares to be transferred at a market premium to key people within Ratos. The intention is that option purchases should be partly subsidised. It is further proposed that the Annual General Meeting decides on a transfer of a maximum of 750,000 shares in the company when the above-mentioned options are exercised.

In addition, the Board proposes that the Annual General Meeting decides to introduce a cash-settled option programme related to Ratos's investments in new holdings. It is proposed to carry out the programme through issuance of synthetic options which key people within Ratos will be entitled to acquire. The programme is essentially identical to the 2007 Option Programme decided at the 2007 Annual General Meeting.

For further information, please contact: Olof Stenhammar, Chairman of the Board, +46 8 700 17 45 Sarah McPhee, Chairman of the Nomination Committee, +46 8 696 31 04

Financial calendar from Ratos:
Annual General Meeting	11 April 2007
Interim report January-March	9 May 2007
Interim report January-June	21 August 2007
Interim report January-September	9 November 2007

Ratos is a listed private equity company. The business concept is to maximise shareholder value over time by investing in, developing and divesting primarily unlisted companies. Ratos offers investors a unique investment opportunity. The equity of Ratos's investments is approximately SEK 12 billion and a market capitalisation of approximately SEK 31 billion. Ratos's holdings include AH Industries, Anticimex, Arcus Gruppen, Bisnode, Camfil, Contex, DIAB, EuroMaint, GS-Hydro, Haendig, Haglöfs, HL Display, HÅG/RH/RBM, Hägglunds Drives, Inwido, Jøtul, Lindab, MCC, Medifiq Healthcare, Superfos and Other holdings.